Anti-proliferative and metastatic protease inhibitory activities of protoberberines: An in silico and in vitro approaches

Process Biochemistry

Volumn 48, Issue 10, 2013, Pages 1565-1571

  Kumari, Seema ^a   Kaladhar, D S V G K ^a   Sandeep Solmon, K ^a   Malla, R R ^a   Kishore, G ^b  

^a GITAM UNIVERSITY   (India)

^b UNIVERSITY OF HYDERABAD   (India)

Author keywords

Cathepsin B; Cell proliferation; In silico docking poses; MMP 9; Protoberberines

Indexed keywords

ANTI-PROLIFERATIVE ACTIVITIES; CATHEPSIN B; EXTRACELLULAR MATRICES; IN-SILICO; MMP-9; OVARIAN CANCER CELLS; PHYSICOCHEMICAL CHARACTERISTICS; PROTOBERBERINES;

BINDING ENERGY; CELL CULTURE; CELL PROLIFERATION; CELLS; PATHOLOGY; REPAIR;

ENZYME INHIBITION;

EID: 84883788183     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2013.06.027     Document Type: Article

References (34)

1. L.-h. Li, I.K. Baeki, J.H. Kimi, K.H. Kangi, Y.S. Koh, and Y.D. Jungi Methanol extract of Elaeagnus glabra, a Korean medicinal plant, inhibits HT1080 tumor cell invasion Oncol Rep 21 2009 559 563
2. A. Jedinák, M. Mucková, D. Kost'álová, T. Maliar, and I. Masterova Antiprotease and antimetastatic activity of ursolic acid isolated from Salvia officinalis Z Naturforsch 61c 2006 777 782
3. E.I. Deryugina, and J.P. Quigley Matrix metalloproteinases and tumor metastasis Cancer Metastasis Rev 25 2006 9 34
4. A. Jedinak, and T. Maliar Inhibitors of proteases as anticancerdrugs Neoplasm 52 2005 185 192
5. K.J. Liu, and G.A. Rosenberg Matrix metalloproteinases and free radicals in cerebral ischemia Free Radic Biol Med 39 1 2005 71 80
6. E.-s. Kim, S.-e. Yoo, K.Y. Yi, S. Lee, J.-s. Noh, and Y.-S. Jung Design, syntheses and biological evaluations of nonpeptidic caspase 3 inhibitors nonpeptidic caspase 3 inhibitors Bull Korean Chem Soc 23 7 2002 1003
7. S. Neidle, and G. Parkinson Telomere maintenance as a target for anticancer drug discovery Nat Rev Drug Discov 1 2002 383 393
8. M.M.A. Rizvi, S.J. Mehdi, A. Ahmad, M. Irshad, and N. Manzoor Cytotoxic effect of Carvacrol on human cervical cancer cells Biol Med 3 2 2011 307 312
9. P. Archana, N. Sathish Kumar, and N. Bharathi In silico docking analysis of curcumin-an inhibitor for obesity Int J Pharma Bio Sci 1 4 2010
10. V. Kettmann, D. Kosfalova, S. Jantova, M. Cernakova, and J. Drímal In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines Pharmazie 59 7 2004 548 551
11. S. Kim, J.H. Choi, J.B. Kim, S.J. Nam, J.-H. Yang, and J.-H. Kim Berberine suppresses TNF-α-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells Molecules 13 2008 2975 2985
12. S.-H. Tee, and S.-K. Mah In silico analysis of oncogenes for renal cancer Int J Adv Sci Eng Inform Technol 2 2012 5
13. T. Mosmann Rapid colorimetric assay for cellular growth andsurvival: application to proliferation and cytotoxicity assays J Immunol Methods 65 1983 55 63
14. A.S. Bajkowski, and A. Frankfater Redistribution of cathepsin B activity from the endosomal-lysosomal pathway in chick intestine within 3 min of calcium absorption Anal Biochem 68 1975 119 127
15. S. Netzel-Arnett, S.K. Mallya, H. Nagase, H. Birkedal-Hansen, and H.E. Van Wart Continuously recording fluorescent assays optimized for five human matrix metalloproteinases Anal Biochem 195 1991 86 92
16. J. Alex Mathew, and N. Nixon Raj Docking studies on anticancer drugs for breast cancer using hex Proceedings of the International Multi-Conference of Engineers and Computer Scientists 2009. IIMECS 2009 18 20
17. G.J.L. Ritchie Kemp "Protein Docking Using Spherical Polar Fourier Correlations", D.W. Proteins: Struct Funct Genet 39 2000 178 194
18. F.L. Scott, J.B. Denault, S.J. Riedl, H. Shin, M. Renatus, and G.S. Salvesen XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs EMBO J 24 2005 645 655
19. C.F. Chantrain, P. Henriet, S. Jodele, H. Emonard, O. Feron, and P.J. Courtoy Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases Eur J Cancer 42 3 2006 310 318
20. R. Ferreira, A. Avino, S. Mazzini, and R. Eritja Synthesis, DNA-binding and antiproliferative properties of acridine and 5-methylacridine derivatives Molecules 17 2012 7067 7082
21. J. Manosroia, P. Dhumtanoma, and A. Manosroia Anti-proliferative activity of essential oil extracted from Thai medicinal plants on KB and P388 cell lines Cancer Lett 235 1 2006 114 120
22. Y. Suna, K. Xun, Y. Wang, and X. Chen A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs Anti-Cancer Drugs 20 9 2009 757 769
23. M.S. Naylor, G.W. Stamp, B.D. Davies, and F.R. Balkwill Expression and activity of MMPS and their regulators in ovarian cancer Int J Cancer 58 1 1994 50 56
24. K.-i. Sakata, M. Someya, M. Omatsu, H. Asanuma, T. Hasegawa, and M. Hareyama The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma BMC Cancer 7 2007 229
25. M. Illemann, N. Bird, A. Majeed, M. Sehested, O.D. Laerum, and L.R. Lund MMP9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases Mol Cancer Res 4 5 2006 293 302
26. A.M. Szpaderska, and A. Frankfater An intracellular form of cathepsin B contributes to invasiveness in cancer Cancer Res 15 61(8) 2001 3493 3500
27. K. Baran, A. Ciccone, C. Peters, H. Yagita, P.I. Bird, and J.A. Villadangos Cytotoxic T lymphocytes from cathepsin B deficient mice survive normally in vitro and in vivo after encountering and killing target cells J Biol Chem 281 41 2006 30485 30491
28. A.T. Chan, Y. Baba, K. Shima, K. Nosho, D.C. Chung, and K.E. Hung Cathepsin B expression and survival in colon cancer: implications for molecular detection of neoplasia Cancer Epidemiol Biomarkers Prev 19 11 2010 2777 2785
29. W.J. Lubbe, Z.Y. Zhou, W. Fu, D. Zuzga, S. Schulz, and R. Fridman Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer Clin Cancer Res 12 6 2006 1876 1882
30. W.P. Daley, S.B. Peters, and M. Larsen Extracellular matrix dynamics in development and regenerative medicine J Cell Sci 21 2008 255 264
31. P.A. Konstantinopoulos, M.V. Karamouzis, A.G. Papatsoris, and A.G. Papavassiliou Matrix metalloproteinase inhibitors as anticancer agents Int J Biochem Biol 40 2008 1156 1168
32. Ertl, B. Rohde, and P. Selzer Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties J Med Chem 43 2000 3714 3717
33. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv Drug Delivery Rev 23 1997 4 25
34. D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward, and K.D. Kopple Molecular properties that influence the oral bioavailability of drug candidates J Med Chem 45 2002 2615 2623